We are live on ! Find out more
ACER

Acer Therapeutics Inc
ACER

Delisted

ACER was delisted on the 8th of November, 2023.

Back to rankings

37 hedge funds and large institutions have $9.6M invested in Acer Therapeutics Inc in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 6

20% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 15

9% more funds holding

Funds holding: 34 → 37 (+3)

87% less capital invested

Capital invested by funds: $76.2M → $9.6M (-$66.6M)

Holders
37
Holders Change
+3
Holders Change %
+8.82%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
11
Reduced
6
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$5.94M
2
RJA
Raymond James & Associates
Florida
+$2.12M
3
NCM
Nantahala Capital Management
Connecticut
+$2.02M
4
State Street
State Street
Massachusetts
+$1.92M
5
JGC
J. Goldman & Co
New York
+$1.91M

Top Sellers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
-$14.1M
2
DCM
Driehaus Capital Management
Illinois
-$9.42M
3
HA
Heartland Advisors
Wisconsin
-$5.35M
4
ACP
Acuta Capital Partners
California
-$3.57M
5
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$3.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$12K -$50.4K -2,642 -47%
AIG
27
American International Group
New York
$12K +$60.8K +3,192 New
First Manhattan
28
First Manhattan
New York
$11K -$191K -10,000 -77%
TRCT
29
Tower Research Capital (TRC)
New York
$8K +$42K +2,202 New
Citigroup
30
Citigroup
New York
$5K -$147K -7,708 -85%
Bank of America
31
Bank of America
North Carolina
$4K -$32.7K -1,717 -63%
AIP
32
Ameritas Investment Partners
Nebraska
$2K +$8.44K +443 New
UBS Group
33
UBS Group
Switzerland
$1K +$4.73K +248 New
BNP Paribas Financial Markets
34
BNP Paribas Financial Markets
France
$51 +$248 +13 New
VC
35
Vivo Capital
California
– -$14.1M -579,051 Closed
DCM
36
Driehaus Capital Management
Illinois
– -$9.42M -387,632 Closed
HA
37
Heartland Advisors
Wisconsin
– -$5.35M -220,000 Closed
ACP
38
Acuta Capital Partners
California
– -$3.57M -147,000 Closed
EMFAT
39
Emerald Mutual Fund Advisers Trust
Pennsylvania
– -$3.04M -125,000 Closed
Millennium Management
40
Millennium Management
New York
– -$1.46M -59,892 Closed
SFM
41
Sphera Funds Management
Israel
– -$1.22M -50,000 Closed
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
– -$598K -24,623 Closed
6CM
43
683 Capital Management
New York
– -$471K -19,367 Closed
AAP
44
Ardsley Advisory Partners
Connecticut
– -$437K -18,000 Closed
ECM
45
ExodusPoint Capital Management
New York
– -$328K -13,493 Closed
TEE
46
Tibra Equities Europe
United Kingdom
– -$297K -12,232 Closed
LCM
47
Laurion Capital Management
New York
– -$253K -10,400 Closed
BGIM
48
Brandywine Global Investment Management
Pennsylvania
– -$149K -6,100 Closed
SG Americas Securities
49
SG Americas Securities
New York
– -$101K -4,136 Closed
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
– -$22.9K -1,204 -93%
1
2
3

ACER Hedge Fund Activity: Q2 2019 in Review

37 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q2 2019, worth a combined $9.6M — down 87% from $76.2M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new ACER positions and 15 closed out — a net gain of 3 holders — while 11 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, adding an estimated $5.94M. The largest seller was Vivo Capital, exiting entirely with an estimated $14.1M sold.

  • 37 institutional investors held Acer Therapeutics Inc (ACER) as of Q2 2019, up from 34 in Q1 2019.
  • Funds reported $9.6M of Acer Therapeutics Inc stock for Q2 2019, down 87% quarter-over-quarter.
  • 18 funds opened new Acer Therapeutics Inc positions in Q2 2019 and 15 closed out, a net change of +3 holders.
  • The largest Acer Therapeutics Inc buyer in Q2 2019 was BlackRock, an estimated $5.94M added.
  • The largest Acer Therapeutics Inc seller in Q2 2019 was Vivo Capital, an estimated $14.1M sold.

Based on aggregated 13F filings for Q2 2019.